Crossmark

Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy

Crossref DOI link: https://doi.org/10.1007/s00404-018-4782-9

Published Online: 2018-05-08

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Froessler, Bernd https://orcid.org/0000-0003-3755-8609
Gajic, Tijana

Dekker, Gustaaf https://orcid.org/0000-0002-7362-6683
Hodyl, Nicolette A. https://orcid.org/0000-0003-2025-5310
License Information

Text and Data Mining valid from 2018-05-08
More Information

Article History

Received: 30 January 2018

Accepted: 30 April 2018

First Online: 8 May 2018

Compliance with ethical standards

:

: BF has received financial support to give lectures, undertake research, attend scientific advisory boards, and undertake consultancies for the New South Wales Department of Health, South Australia Department of Health, Australian Red Cross Blood Service, Australian National Blood Authority, Vifor Pharma Ltd., Switzerland, and CSL Behring Australia. No support was received from any organization for the submitted work. TG, GD, and NH declare that they have no conflict of interest.